Kirschner LSGaining traction in the treatment of adrenocortical carcinoma.J Clin Endocrinol Metab 98(1) 45-7 1/1/2013
Manchanda PK, Jones GN, Lee AA, Pringle DR, Zhang M, Yu L, La Perle KM, Kirschner LSRac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors.Oncogene in press 10/8/2012
Kirschner LSThe next generation of therapies for adrenocortical cancers.Trends Endocrinol Metab 23(7) 343-50 7/1/2012
Pringle DR, Yin Z, Lee AA, Manchanda PK, Yu L, Parlow A, Jarjoura D, Laperle KM, Kirschner LThyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.Endocr Relat Cancer 19(3) 435-46 6/1/2012
Demeure MJ, Bussey KJ, Kirschner LSTargeted therapies for adrenocortical carcinoma: IGF and beyond.Horm Cancer 2(6) 385-92 12/1/2011
Yin Z, Pringle DR, Jones GN, Kelly KM, Kirschner LSDifferential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.Mol Endocrinol 25(10) 1786-93 10/1/2011